How Well Are Randomized Controlled Trials Reported in the Dermatology Literature?
Authors:
- Kayode AdetugboKAKayode Adetugbo
- Hywel WilliamsHWHywel Williams
Open Access
- 1 March 2000
- journal article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 136 (3) , 381-385
Abstract
WELL-DESIGNED clinical trials yield strong evidence for the effects of health care interventions. The randomized controlled trial (RCT) is the criterion standard for clinical trials and offers the most robust and rigorous way of determining the causal relationship between treatment and effect and for assessing the cost-effectiveness of a treatment.1-7 Random assignment greatly reduces the potential for bias in the allocation of interventions. It ensures that comparison groups are as similar as possible to each other in terms of both known and unknown possible predictors of treatment response,6 and RCTs have been consistently shown to give more reliable evidence of therapeutic effectiveness than nonrandomized studies.3 Even so, there are some limitations and skepticism regarding the use and value of randomized trials.7-10Keywords
This publication has 11 references indexed in Scilit:
- Content and quality of 2000 controlled trials in schizophrenia over 50 yearsBMJ, 1998
- Why we need observational studies to evaluate the effectiveness of health careBMJ, 1996
- Inadequate size of 'negative' clinical trials in dermatologyBritish Journal of Dermatology, 1993
- Randomisation and baseline comparisons in clinical trialsThe Lancet, 1990
- Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgeryJACC, 1988
- A quality assessment of randomized control trials of primary treatment of breast cancer.Journal of Clinical Oncology, 1986
- Reporting on Methods in Clinical TrialsNew England Journal of Medicine, 1982
- Randomized versus historical controls for clinical trialsThe American Journal of Medicine, 1982
- Problems of clinical trials as evidence of therapeutic effectivenessSocial Science & Medicine, 1982
- Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial InfarctionNew England Journal of Medicine, 1977